This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Carl Shapiro is a panelist during the session titled “Some call it “newBrandeis” some call it hipster – either way, is there now such a thing as too big?”
For more information on this event, click here.
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...
FTCWatch recently conducted an in-depth interview with Vice President Nate Goldstein, exploring his transition from a distinguished 23-year tenure at the...
The Annual CRA Brussels Conference, to be held exclusively at the Steigenberger Wiltcher’s Hotel on Tuesday, 9 December 2025, will focus on the pursuit of...
Yajing Jiang moderates the latest Groundbreakers seminar, featuring Leon Musolff’s paper (co-authored with Kwok-Hao Lee), “Two-Sided Markets and...
